Pancreatic Cancer Market Information: By Type (Endocrine Pancreas Cancer and Exocrine Pancreas Cancer), Treatment (Hormone Therapy, Biologic Therapy, and Targeted Therapy), End User (Hospitals & Clinics and Research Institute) – Global Forecast till 2023. pancreatic cancer is currently in clinical trials, providing potential new options for patients with this difficult-to-treat cancer. A new discovery about pancreatic cancer sheds light on how the cancer fuels its growth and may help explain how promising cancer drugs work
KEY MARKET PLAYERS
There are various market players operating in the global pancreatic cancer market. PharmaCyte Biotech, Inc.; Clovis Oncology; Teva Pharmaceutical Industries Ltd.; Merck & Co., Inc.; and Pfizer, Inc.
Global Pancreatic Cancer Market – Overview
The global pancreatic cancer market, as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period (2017-2023).
Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease.
Pancreatic Cancer is an enlarged tumor caused by malignant cells in the tissues of the pancreas. The pancreas are organ situated behind the stomach. Pancreatic cancer can be caused by smoking, drinking alcohol, radiotherapy in the past, genetic factors, age, inflammation of the pancreas, obesity, and diabetes mellitus. According to Cancer Research UK, 7 out of 10 cases of chronic pancreatitis are due to heavy drinking habits.
Rising rates in tobacco consumption, increasing cigarette smokers are likely to enhance the growth of pancreatic cancer market. Additionally, rising prevalence of cancer, increase in intake of alcohol, growing obesity rates, and growing awareness pertaining to various treatment options available are propelling the market growth at a global level.
However high costs, and the side effects related to the treatment of pancreatic cancer are likely to hamper the growth of pancreatic cancer market.
Free Sample Report of Pancreatic Cancer Market : https://www.marketresearchfuture.com/sample_request/1638
On August 2019, a team of scientists at the Huntsman Cancer Institute made discoveries in the treatment of pancreatic cancer. The researchers discovered that the growth of cancer could be blocked by turning on a protein used by pancreas cells.
Founded in 1980, and headquartered at US, Celgene Corporation is a biopharmaceutical company aimed in the detection and development of treatments for various cancers and inflammatory diseases. Celgene Corporation has its presence all over the world. The firm has focused on various inorganic and organic growth strategies to enhance its services and increase its patient base. For instance in the year 2015, Celgene Corporation received approval from European Commission (EC) for ABRAXANE, a nanotechnology therapy for the treatment of metastatic pancreatic cancer.
The firm has been focusing on improving lives of patients with pancreatic cancer. For instance in 2015, Celgene Corporation invested 30% of its revenue on research and development to produce advanced technologies to support patients with pancreatic cancer. By this approval and high research and development expenditure, the firm aims to focus on patient needs and increase its customer base.
Founded in 1895, and headquartered in Switzerland, Novartis AG is engaged in the manufacture and development of a wide range of healthcare products. In 2016, Novartis and Pfizer collaborated to form a study on tumors driven by mutations in a gene called KRAS that causes cancer. Additionally, in 2017 Novartis and Perthera partnered to support clinical trials for lung cancer patients. This collaboration and partnership enables the firm to widen its foothold in various geographies.
Browse full report of Pancreatic Cancer Market @ https://www.marketresearchfuture.com/reports/pancreatic-cancer-market-1638
Geographically, the pancreatic cancer market is segmented into four key regions: the Americas, Europe, Asia Pacific, and Middle East & Africa. The Americas is further segmented into North America and South America. And North America is segmented into the U.S. and Canada. Globally, the U.S. is the largest market for pancreatic cancer owing to rising prevalence of cancer, increasing consumption of alcohol, increase in per capita R&D spending, along with rise in demand for new and advanced products and techniques.
Asia pacific region is expected to be fastest growing region in pancreatic cancer market owing to its growing population and eventually growing patient population. Additionally, increasing healthcare expenditure and growing demand for newer and advanced technologies to treat the growing demand for increasing prevalence of cancer. For instance, US Census Bureau has estimated that by 2050, two third of the world’s older population will reside in Asia.
Similarly increasing healthcare spending is likely to grow the demand for pancreatic cancer market. Similarly, according to CMS (Centres for Medicare and Medicaid Services) U.S. health care spending increased 4.3 percent to reach USD 3.3 trillion per person in 2016.For instance, according to National cancer institute, in 2016, around 1,685,210 new cases of cancer were diagnosed in the U.S. Similarly, in 2016, U.S. spent over USD 125 billion for cancer care and is expected to spend over USD 156 billion by 2020. According to CDC, around one third of the population is affected with obesity.
Europe accounts for the second largest market due to rising incidence of cancer, growth in research and development to produce advanced technologies, increasing funds, government support and increasing healthcare expenditure. For instance according to Eurostat, Germany spend over EUR 321 billion in the year 2014. Similarly, according to cancer research UK, there were around 9, 921 cases of cancer diagnosed in 2015. This high incidence of cancer is likely to enhance the growth of pancreatic cancer market.
On the other hand, the Middle East & Africa is expected to witness limited growth due to limited access to the healthcare resources and rising healthcare cost. In the Middle East, the growth of the market is driven by increasing research and development for newer technologies and rising healthcare infrastructure.
Table Of Content
2.2 Scope Of The Study
2.2.1 Research Objective
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5.Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
6.Global Pancreatic Cancer Market, By Type
6.2 Endocrine Pancreas Cancer
6.2.1 Market Estimates & Forecast, 2017-2023
6.3 Exocrine Pancreas Cancer
6.3.1 Market Estimates & Forecast, 2017-2023
6.4.1 Market Estimates & Forecast, 2017-2023
7.Global Pancreatic Cancer Market, By Treatment
7.2.1 Market Estimates & Forecast, 2017-2023
7.3 Surgery & Radiation Therapy
7.3.1 Market Estimates & Forecast, 2017-2023
7.4 Targeted Therapy
7.4.1 Market Estimates & Forecast, 2017-2023
7.5 Biologic Therapy
7.5.1 Market Estimates & Forecast, 2017-2023
7.6 Hormone Therapy
7.6.1 Market Estimates & Forecast, 2017-2023
7.7.1 Market Estimates & Forecast, 2017-2023
9.Global Pancreatic Cancer Market, By End User
8.2 Hospitals & Clinics
8.2.1 Market Estimates & Forecast, 2017-2023
8.3 Research Institute
8.3.1 Market Estimates & Forecast, 2017-2023
8.4.1 Market Estimates & Forecast, 2017-2023
9.Global Pancreatic Cancer Market, By Region others…
LIST OF TABLES
Table 1 Pancreatic Cancer Industry Synopsis, 2017-2023
Table 2 Global Pancreatic Cancer Market Estimates And Forecast, 2017-2023, (USD Million)
Table 3 Global Pancreatic Cancer Market By Region, 2017-2023, (USD Million)
Table 4 Global Pancreatic Cancer Market By Type, 2017-2023, (USD Million)
Table 5 Global Pancreatic Cancer Market By Treatment, 2017-2023, (USD Million)
Table 6 Global Pancreatic Cancer Market By End Users, 2017-2023, (USD Million)
Table 7 North America Pancreatic Cancer Market By Type, 2017-2023, (USD Million)
Table 8 North America Pancreatic Cancer Market By Treatment, 2017-2023, (USD Million)
Table 9 North America Pancreatic Cancer Market By End Users, 2017-2023, (USD Million)
Table 10 US Pancreatic Cancer Market By Type, 2017-2023, (USD Million)
Table 11 US Pancreatic Cancer Market By Treatment, 2017-2023, (USD Million) others……
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Global Pancreatic Cancer Market
Figure 3 Segmentation Market Dynamics For Pancreatic Cancer Market
Figure 4 Global Pancreatic Cancer Market Share, By Type 2016
Figure 5 Global Pancreatic Cancer Market Share, By Treatment 2016
Figure 6 Global Pancreatic Cancer Market Share, By End Users, 2016
Figure 7 Global Pancreatic Cancer Market Share, By Region, 2016
Figure 8 America Pancreatic Cancer Market Share, By Country, 2016
Figure 9 Europe Pancreatic Cancer Market Share, By Country, 2016
Figure 10 Asia Pacific Pancreatic Cancer Market Share, By Country, 2016
Figure 11 Middle East & Africa Pancreatic Cancer Market Share, By Country, 2016
Figure 12 Global Pancreatic Cancer Market: Company Share Analysis, 2016 (%)
Figure 13 Eli Lilly And Company: Key Financials
Figure 14 Eli Lilly And Company: Segmental Revenue
Figure 15 Eli Lilly And Company: Geographical Revenue others….
For More Enquiry @ https://www.marketresearchfuture.com/report_info.pdf?report_id=1638
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
+1 646 845 9312